Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis

. 2024 Apr 01 ; 19 (4) : 438-451. [epub] 20240123

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38261310

Grantová podpora
Cedars-Sinai Medical Center

Odkazy

PubMed 38261310
PubMed Central PMC11020428
DOI 10.2215/cjn.0000000000000398
PII: 01277230-202404000-00007
Knihovny.cz E-zdroje

BACKGROUND: Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts. METHODS: Biopsies from 262 children and 99 adults with IgA vasculitis nephritis ( N =361) from 23 centers in North America, Europe, and Asia were independently scored by three pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients ( N =309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using latent class mixed models to identify classes of eGFR trajectories over a median follow-up of 2.7 years (interquartile range, 1.2-5.1). Clinical and histologic parameters associated with each class were determined using logistic regression. RESULTS: M, E, T, and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by latent class mixed model, one with initial improvement in eGFR followed by a late decline (class 1, N =91) and another with stable eGFR (class 2, N =218). Class 1 was associated with a higher risk of an established kidney outcome (time to ≥30% decline in eGFR or kidney failure; hazard ratio, 5.84; 95% confidence interval, 2.37 to 14.4). Among MEST-C scores, only E1 was associated with class 1 by multivariable analysis. Other factors associated with class 1 were age 18 years and younger, male sex, lower eGFR at biopsy, and extrarenal noncutaneous disease. Fibrous crescents without active changes were associated with class 2. CONCLUSIONS: Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.

Bambino Gesù Children's Hospital IRCCS Rome Italy

BC Renal Vancouver British Columbia Canada

Centre for Research on Inflammation Bichat Hospital Inserm and Université Paris Cité Paris France

Clinical Research Center Takatsuki General Hospital Wakayam Medical University Takatsuki City Japan

Comitato Tecnico Scientifico per la Ricerca e Innovaziione A O Santobono Pausilipon Naples Italy

Department of Cellular Pathology Oxford University Hospitals NHS FT Oxford United Kingdom

Department of Children and Adolescents Oulu University Hospital Oulu Finland

Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota

Department of Laboratory Medicine and Pathology University of Washington Medical Center Seattle Washington

Department of Medicine and Surgery IRCCS San Gerardo University Milan Bicocca Monza Italy

Department of Medicine Division of Nephrology Johns Hopkins University School of Medicine Baltimore Maryland

Department of Metabolism Endocrinology and Molecular Medicine Osaka Metropolitan University Graduate School of Medicine Osaka Japan

Department of Nephrology 1st Faculty of Medicine and General University Hospital Charles University Prague Czech Republic

Department of Nephrology 1st Faculty of Medicine General University Hospital Prague Czech Republic

Department of Nephrology and Hypertension Jikei University School of Medicine Tokyo Japan

Department of Nephrology Juntendo University Faculty of Medicine Tokyo Japan

Department of Pathology and Laboratory Medicine Cedars Sinai Medical Center Los Angeles California

Department of Pathology and Laboratory Medicine University of North Carolina School of Medicine Chapel Hill North Carolina

Department of Pathology and Medical Biology University of Groningen Groningen The Netherlands

Department of Pathology AP HP Hôpital Bichat Université Paris Cité Paris France

Department of Pathology Johns Hopkins University School of Medicine Baltimore Maryland

Department of Pathology Mass General Brigham Salem Hospital Salem Massachusetts

Department of Pathology Microbiology and Immunology Vanderbilt University Medical Center Nashville Tennessee

Department of Pathology The Jikei University School of Medicine Tokyo Japan

Department of Pathology University of Kentucky Medical Center Lexington Kentucky

Department of Pathology University of Toronto Toronto Ontario Canada

Department of Pathology University of Utah Salt Lake City Utah

Department of Pathology Washington University in Saint Louis St Louis Missouri

Department of Pediatric Nephrology and Transplantation New Children's Hospital University of Helsinki and Helsinki University Hospital Helsinki Finland

Department of Pediatrics Peking University 1st Hospital Beijing China

Department of Pediatrics University of Tennessee Health Sciences Center Memphis Tennessee

Department of Pediatrics Wakayama Medical University Wakayama Japan

Division of Dialysis Department of Nephrology University of Miyazaki Hospital Miyazaki Japan

Division of Nephrology and Hypertension Department of Internal Medicine Jikei University School of Medicine Tokyo Japan

Division of Nephrology and Hypertension Department of Internal Medicine St Marianna University School of Medicine Kanagawa Japan

Division of Nephrology and Hypertension Mayo Clinic Rochester Minnesota

Division of Nephrology Bambino Gesù Children's Hospital IRCCS Rome Italy

Division of Nephrology University of British Columbia Vancouver British Columbia Canada

Division of Pediatric Nephrology Department of Pediatrics University of Utah Salt Lake City Utah

Division of Pediatric Nephrology University of British Columbia Vancouver British Columbia Canada

Fondazione Ricerca Molinette Regina Margherita Hospital Turin Italy

Imperial College London London United Kingdom

INSERM U1149 and Université Paris Cité Paris France

Institute of Pathology University Hospital of Cologne Cologne Germany

Kidney Center Department of Internal Medicine Nephrology Teikyo University School of Medicine Teikyo University Chiba Medical Center Chiba Japan

Kidney Division Department of Medicine Peking University 1st Hospital Peking University Institute of Nephrology Beijing China

Kidney Unit National Hospital Organization Fukuokahigashi Medical Center Fukuoka Japan

Laboratory of Electron Microscopy Pathological Center Peking University 1st Hospital Beijing China

Medical Center Department of General Pediatrics Adolescent Medicine and Neonatology Faculty of Medicine University of Freiburg Freiburg Germany

Medical Center University of Freiburg and Faculty of Medicine Institute for Surgical Pathology University of Freiburg Freiburg Germany

National Clinical Research Center of Kidney Diseases Jinling Hospital Nanjing University School of Medicine Nanjing China

Nephrology and Dialysis Unit AOU G Martino University of Messina Messina Italy

Nephrology and Dialysis Unit Meyer Children's Hospital Florence Italy

Nephrology Bichat Hospital AP HP Paris France

Nephrology Unit Saint Louis Hospital Paris France

Pathology Department Bambino Gesù Children's Hospital Rome Italy

Pathology Section Department of Public Health School of Medicine University of Naples Federico 2 Naples Italy

Pathology Unit Città della Salute e della Scienza di Torino University Hospital Turin Italy

Pathology University Oulu and Oulu University Hospital Oulu Finland

PEDEGO Research Unit Research Unit for Pediatrics Dermatology Clinical Genetics Obstetrics and Gynecology Medical Research Center Oulu Oulu Finland

Pediatric Nephrology and Rheumatology Unit AOU Policlinic G Martino University of Messina Messina Italy

Pediatric Nephrology Dialysis and Transplant Unit Department of Women's and Child's Health Azienda Ospedaliera University of Padova Padua Italy

Pediatric Nephrology Dialysis and Transplant Unit Fondazione IRCC Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Pediatric Nephrology Faculty of Medicine and University Hospital Cologne Children's and Adolescents' Hospital University of Cologne Cologne Germany

Pediatric Nephrology Unit Regina Margherita Children's Hospital AOU Città della Salute della Scienza di Torino Turin Italy

Pediatrics Clinical Trials Office University of Utah Salt Lake City Utah

Renal Division Peking University 1st Hospital Beijing China

Texas Children's Hospital Houston Texas

Komentář v

doi: 10.2215/CJN.0000000000000444 PubMed

Zobrazit více v PubMed

Davin JC, Coppo R. Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–573. doi:10.1038/nrneph.2014.126 PubMed DOI

Hastings MC Rizk DV Kiryluk K, et al. . IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol. 2022;37(4):719–733. doi:10.1007/s00467-021-04950-y PubMed DOI PMC

Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant. 1998;13(4):930–934. doi:10.1093/ndt/13.4.930 PubMed DOI

Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78(6):395–409. doi:10.1097/00005792-199911000-00005 PubMed DOI

Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, Flageul B, Morel P, Rybojad M. Schonlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. Arch Dermatol. 1997;133(4):438–442. doi:10.1001/archderm.133.4.438 PubMed DOI

Haas M. IgA nephropathy and IgA vasculitis (Henoch-Schonlein purpura) nephritis. In: Jenette JC, Olsen JL, Silva FG, D’Agati VD, eds. Hepinstall’s Pathology of the Kidney, 7th ed. Wolters-Kluwer; 2015:463–523.

Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura). Autoimmun Rev. 2017;16(12):1246–1253. doi:10.1016/j.autrev.2017.10.009 PubMed DOI

Koskela M Ylinen E Ukonmaanaho EM, et al. . The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2017;32(7):1201–1209. doi:10.1007/s00467-017-3608-5 PubMed DOI

Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol. 1999;13(9):816–823. doi:10.1007/s004670050707 PubMed DOI

Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in Henoch-Schonlein nephritis. Pediatr Nephrol. 2010;25(6):1101–1108. doi:10.1007/s00467-010-1444-y PubMed DOI

Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271–1278. doi:10.1097/01.ASN.0000013883.99976.22 PubMed DOI

Cattran DC Coppo R Cook HT, et al. .; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–545. doi:10.1038/ki.2009.243 PubMed DOI

Coppo R Troyanov S Bellur S, et al. . Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86(4):828–836. doi:10.1038/ki.2014.63 PubMed DOI PMC

Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int. 2014;85(4):779–793. doi:10.1038/ki.2013.375 PubMed DOI

Roberts ISD Cook HT Troyanov S, et al. .; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–556. doi:10.1038/ki.2009.168 PubMed DOI

Barbour SJ Espino-Hernandez G Reich HN, et al. . The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int. 2016;89(1):167–175. doi:10.1038/ki.2015.322 PubMed DOI

Barbour SJ Coppo R Zhang H, et al. . Evaluating a new international risk-prediction Tool in IgA nephropathy. JAMA Intern Med. 2019;179(7):942–952. doi:10.1001/jamainternmed.2019.0600 PubMed DOI PMC

Zhang Y Guo L Wang Z, et al. . External validation of international risk-prediction models of IgA nephropathy in an asian-Caucasian cohort. Kidney Int Rep. 2020;5(10):1753–1763. doi:10.1016/j.ekir.2020.07.036 PubMed DOI PMC

Kidney Disease Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical Practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–S276. doi:10.1016/j.kint.2021.05.021 PubMed DOI

Kim CH Lim BJ Bae YS, et al. . Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schonlein purpura nephritis in adults. Mod Pathol. 2014;27(7):972–982. doi:10.1038/modpathol.2013.222 PubMed DOI

Huang X Ma L Ren P, et al. . Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schonlein purpura nephritis. Diagn Pathol. 2019;14(1):40. doi:10.1186/s13000-019-0818-0 PubMed DOI PMC

Cakici EK Gur G Yazilitas F, et al. . A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol. 2019;23(7):939–947. doi:10.1007/s10157-019-01726-5 PubMed DOI

Jimenez A, Chen A, Lin JJ, South AM. Does MEST-C score predict outcomes in pediatric Henoch-Schonlein purpura nephritis?. Pediatr Nephrol. 2019;34(12):2583–2589. doi:10.1007/s00467-019-04327-2 PubMed DOI PMC

Xu K Zhang L Ding J, et al. . Value of the Oxford classification of IgA nephropathy in children with Henoch-Schonlein purpura nephritis. J Nephrol. 2018;31(2):279–286. doi:10.1007/s40620-017-0457-z PubMed DOI

Barbour SJ Coppo R Er L, et al. . Updating the international IgA nephropathy prediction Tool for use in children. Kidney Int. 2021;99(6):1439–1450. doi:10.1016/j.kint.2020.10.033 PubMed DOI

Trimarchi H Barratt J Cattran DC, et al. . Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014–1021. doi:10.1016/j.kint.2017.02.003 PubMed DOI

Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F.; German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20(10):1995–2007. doi:10.1097/00004872-200210000-00019 PubMed DOI

Hogan MC Reich HN Nelson PJ, et al. . The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int. 2016;90(5):1080–1089. doi:10.1016/j.kint.2016.06.020 PubMed DOI PMC

Pottel H Hoste L Dubourg L, et al. . An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31(5):798–806. doi:10.1093/ndt/gfv454 PubMed DOI PMC

Gwet KL. Handbook of Inter-rater Reliability: The Definitive Guide to Measuring the Extent of Agreement Among Raters, 4 ed. Advanced Analytics LLC; 2014.

Hallgren KA. Computing inter-rater reliability for observational data: an overview and tutorial. Tutor Quant Methods Psychol. 2012;8(1):23–34. doi:10.20982/tqmp.08.1.p023 PubMed DOI PMC

Dancey CP, Reidy J. Statistics without Maths for Psychology: Using SPSS for Windows, 4 ed. Prentice Hall; 2007.

Herle M Micali N Abdulkadir M, et al. . Identifying typical trajectories in longitudinal data: modelling strategies and interpretations. Eur J Epidemiol. 2020;35(3):205–222. doi:10.1007/s10654-020-00615-6 PubMed DOI PMC

Nguena Nguefack HL Page MG Katz J, et al. . Trajectory modelling techniques useful to epidemiological Research: a comparative narrative review of approaches. Clin Epidemiol. 2020;12:1205–1222. doi:10.2147/CLEP.S265287 PubMed DOI PMC

Boucquemont J Loubere L Metzger M, et al. . Identifying subgroups of renal function trajectories. Nephrol Dial Transplant. 2017;32(suppl 2):ii185–ii193. doi:10.1093/ndt/gfw380 PubMed DOI

Bellur SS Roberts ISD Troyanov S, et al. . Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort. Nephrol Dial Transplant. 2019;34(10):1681–1690. doi:10.1093/ndt/gfy337 PubMed DOI

Koskela M Ylinen E Autio-Harmainen H, et al. . Prediction of renal outcome in Henoch-Schonlein nephritis based on biopsy findings. Pediatr Nephrol. 2020;35(4):659–668. doi:10.1007/s00467-019-04415-3 PubMed DOI PMC

Haas M Verhave JC Liu ZH, et al. . A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrol. 2017;28(2):691–701. doi:10.1681/ASN.2016040433 PubMed DOI PMC

Trimarchi H, Haas M, Coppo R. Crescents and IgA nephropathy: a delicate marriage. J Clin Med. 2022;11(13):3569. doi:10.3390/jcm11133569 PubMed DOI PMC

Peruzzi L, Coppo R. IgA vasculitis nephritis in children and adults: one or different entities? Pediatr Nephrol. 2021;36(9):2615–2625. doi:10.1007/s00467-020-04818-7 PubMed DOI

Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. Clin Nephrol. 1987;28(3):118–124. PMID: 3665204 PubMed

Coppo R Andrulli S Amore A, et al. . Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis. 2006;47(6):993–1003. doi:10.1053/j.ajkd.2006.02.178 PubMed DOI

Lv J Wong MG Hladunewich MA, et al. . Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2022;327(19):1888–1898. doi:10.1001/jama.2022.5368 PubMed DOI PMC

Lafayette R Kristensen J Stone A, et al. . Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023;402(10405):859–870. doi:10.1016/S0140-6736(23)01554-4 PubMed DOI

Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet. 1992;339(8788):280–282. doi:10.1016/0140-6736(92)91341-5 PubMed DOI

Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet. 2002;360(9334):666–670. doi:10.1016/S0140-6736(02)09835-5 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...